90 filings
Page 2 of 5
8-K
0sq67plxpam8ra
10 Mar 22
Codiak BioSciences Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Operational Progress
4:07pm
8-K
ec42zumd22jub1890
30 Nov 21
Patient Dosing Expected 1H 2022
8:36am
8-K
rjd5s
17 Nov 21
Regulation FD Disclosure
7:00am
8-K
wekqsrgqf j6a45r2
16 Nov 21
Entry into a Material Definitive Agreement
6:58am
EFFECT
acpkjqvml8
16 Nov 21
Notice of effectiveness
12:15am
UPLOAD
51zj hzd7
12 Nov 21
Letter from SEC
12:00am
CORRESP
l6xueqnnu7m776
12 Nov 21
Correspondence with SEC
12:00am
8-K
9t3e6al9rbp 1oqlni
4 Nov 21
Entry into a Material Definitive Agreement
5:27pm
S-3
fhq6dqaxv2if2
4 Nov 21
Shelf registration
5:04pm
8-K
n4a0fu9rszt
4 Nov 21
Codiak BioSciences Reports Third Quarter 2021 Financial Results and Recent Operational Progress
4:07pm
8-K
r39os4
2 Nov 21
Lonza to Acquire Codiak BioSciences Exosomes Manufacturing Facility and Establish a Long-Term Strategic Collaboration
8:08am
8-K
2sj9g
7 Oct 21
Termination of a Material Definitive Agreement
4:16pm
8-K
glgp8qdl
21 Sep 21
Entry into a Material Definitive Agreement
4:01pm
8-K
2dny65clj0nr
18 Aug 21
Departure of Directors or Certain Officers
4:06pm
8-K
xh3vu w86gy
5 Aug 21
Codiak BioSciences Reports Second Quarter 2021 Financial Results and Operational Progress
4:08pm
8-K
1tygn5s32ho6nx
6 Jul 21
Departure of Directors or Certain Officers
5:01pm
8-K
wcg85m 8gmr7zu29d3
23 Jun 21
Submission of Matters to a Vote of Security Holders
4:05pm